FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1963526020> ?p ?o ?g. }

• W1963526020 endingPage "15" @default.
• W1963526020 startingPage "1" @default.
• W1963526020 abstract "Annals of the New York Academy of SciencesVolume 427, Issue 1 p. 1-15 SELECTIVITY OF ANTIARRHYTHMIC DRUGS AND IONIC CHANNELS: A HISTORICAL OVERVIEW Edward Carmeliet, Edward Carmeliet Laboratory of Physiology University of Leuven Campus Gasthuisberg 3000 Leuven, BelgiumSearch for more papers by this author Edward Carmeliet, Edward Carmeliet Laboratory of Physiology University of Leuven Campus Gasthuisberg 3000 Leuven, BelgiumSearch for more papers by this author First published: November 1984 https://doi.org/10.1111/j.1749-6632.1984.tb20771.xCitations: 13AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Bassett, A. L. & B. F. Hoffman. 1971. Antiarrhythmic drugs: electrophysiological actions. Annu. Rev. Pharmacol. 11: 143–170. 2 Davis, L. D. & J. V. Temte. 1969. Electrophysiological actions of lidocaine on canine ventricular muscle and Purkinje fibers. Circ. Res. 44: 639–655. 3 Bigger, J. T. & W. J. Mandel. 1970. Effect of lidocaine on the electrophysiological properties of ventricular muscle and Purkinje fibers. J. Clin. Invest. 49: 63–77. 4 Vaughan Williams, E. M. 1970. Classification of antiarrhythmic drugs. In Symposium on cardiac arrhythmias. E. Sandoe, E. Flensted-Jensen & K. H. Olesen, Eds.: 449–472. Astra. Sweden . 5 Mandel, W. J. & J. T. Bigger. 1970. Effect of lidocaine on the electrophysiological properties of ventricular muscle and Purkinje fibers. J. Clin. Invest. 49: 63–77. 6 Singh, B. N. & E. M. Vaughan-Williams. 1971. Effect of altering potassium concentration on the action of lidocaine and diphenylhydantoin on rabbit atrial and ventricular muscles. Circ. Res. 29: 286–295. 7 Jensen, R. A. & B. G. Katzung. 1970. Electrophysiological action of diphenylhydantoin on rabbit atria. Dependence on stimulation frequency, potassium, and sodium. Circ. Res. 26: 17–27. 8 Dreyfus, L. S., I. M. de Azevedo & Y. Watanabe. 1974. Electrolyte and antiarrhythmic drug interaction. Am. Heart J. 88: 95–107. 9 Chen, C.-M., L. S. Gettes & B. Katzung. 1975. Effect of lidocaine and quinidine on steady-state characteristics and recovery kinetics of (dV/dt)max in guinea-pig ventricular myocardium. Circ. Res. 37: 20–29. 10 Weidmann, S. 1955. The effects of calcium ions and local anesthetics on electrical properties of Purkinje fibres. J. Physiol. (London) 129: 568–582. 11 Hondeghem, L. M., A. O. Grant & R. A. Jensen. 1974. Antiarrhythmic drug action: selective depression of hypoxic cardiac cells. Am. Heart J. 87: 602–605. 12 Sasyniuk, B. I. & T. Kus. 1974. Comparison of the effects of lidocaine on the electrophysiological properties of normal Purkinje fibers and those surviving acute myocardial infarction. Fed. Proc. Fed. Am. Soc. Exp. Biol. 33: 470 (Abstr.). 13 Kupersmith, J., E. M. Antman & B. F. Hoffman. 1975. In vivo electrophysiological effects of lidocaine in canine acute myocardial infarction. Circ. Res. 36: 84–91. 14 El-Sherif, M., B. J. Scherlag, R. Lazzara & R. R. Hope. 1977. Re-entrant ventricular arrhythmias in the late myocardial infarction period. Mechanism of action of lidocaine. Circulation 56: 395–404. 15 Bean, B. P., C. J. Cohen & R. W. Tsien. 1983. Lidocaine block of cardiac sodium channels. J. Gen. Physiol. 81: 613–642. 16 Carmeliet, E. & T. Saikawa. 1982. Shortening of the action potential and reduction of pacemaker activity by lidocaine, quinidine and procainamide in sheep cardiac Purkinje fibers. An effect on Na or K currents Circ. Res. 50: 257–272. 17 Corn, H. J. Jr. & J. C. Wood. 1960. Acute effects of quinidine on K exchange and distribution in the dog ventricle. Am. J. Physiol. 199: 151. 18 Colatsky, T. J. 1982. Mechanisms of action of lidocaine and quinidine on action potential duration in rabbit cardiac Purkinje fibers. An effect on steadystate sodium currents. Circ. Res. 50: 17–27. 19 Weld, F. M. & J. T. Bigger. 1976. The effect of lidocaine on diastolic transmembrane currents determining pacemaker depolarization in cardiac Purkinje fibers. Circ. Res. 38: 203–208. 20 Hondeghem, L. M. & B. G. Katzung. 1977. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim. Biophys. Acta 472: 373–398. 21 Johnson, E. A. & M. C. McKinnon. 1957. The differential effect of quinidine and pyrilamine on the myocardial action potential at various rates of stimulation. J. Pharmacol. Exp. Ther. 120: 460–468. 22 Heistracher, P. 1971. Mechanism of action of antifibrillatory drugs. Naunyn-Schmiedeberg's Arch. Pharmakol. 269: 199–212. 23 Ducouret, P. 1976. The effect of quinidine on membrane electrical activity in frog auricular fibres studied by current and voltage clamp. Br. J. Pharmacol. 57: 163–184. 24 Hille, B. 1977. Local anesthetics: hydrophilic and hydrophobic pathways for drug-receptor reaction. J. Gen. Physiol. 69: 497–515. 25 Lee, K. S., J. R. Hume, W. Giles & A. M. Brown. 1981. Sodium current depression by lidocaine and quinidine in isolated ventricular cells. Nature (London) 291: 325–327. 26 Strichartz, G. R. 1973. The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine. J. Gen. Physiol. 62: 37–57. 27 Schwarz, W., P. T. Palade & B. Hille. 1977. Local anesthetics. Effect of pH on use-dependent block of sodium channels in frog muscle. Biophys. J. 30: 343–368. 28 Courtney, K. R. 1980. Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardium. J. Mol. Cell. Cardiol. 12: 1273–1286. 29 Sanchez-Chapula, J., Y. Tsuda, I. Josephson & A. M. Brown. 1982. Effects of lidocaine and benzocaine on cardiac sodium current. Biophys. J. 37: 238a (Abstr.). 30 Fleckenstein, A., H. Kammermeier, H. J. Döring & H. J. Freund. 1967. Zum Wirkungsmechanismus neuartiger Koronardilatatoren mit gleichzeitig Sauerstoff-einsparenden Myokard-Effekten, Prenylamin und Iproveratril. Z. Kreislaufforsch. 56: 716–744. 31 Kohlhardt, M., B. Bauer, H. Krause & A. Flechenstein. 1972. Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibres by the use of specilic inhibitors. Pflügers Arch. 335: 309–322. 32 Kass, R. S. & R. W. Tsien. 1975. Multiple effects of calcium antagonists on plateau currents in cardiac Purkinje fibers. J. Gen. Physiol. 66: 169–192. 33 Nawrath, H., R. E. TenEick, T. F. McDonald & W. Trautwein. 1977. On the mechanism underlying the action of D600 on slow inward current and tension in mammalian myocardium. Circ. Res. 40: 408–414. 34 Trautwein, W., D. Pelzer, T. F. McDonald & W. Osterrieder. 1981. AQA39, a new bradycardiac agent which blocks myocardial calcium (Ca) channels in a frequency- and voltage-dependent manner. Naunyn Schmiedeberg's Arch. Pharmakol. 317: 228–232. 35 Ehara, T. & R. Kaufmann. 1978. The voltage- and time-dependent effects of (-)-erapamil on the slow inward current in isolated cat ventricular myocardium. J. Pharmacol. Exp. Ther. 207: 49–55. 36 Lee, K. S., E. W. Lee & R. W. Tsien. 1982. Comparison between Ca2+ channel block by Cd2+ and D600, in single mammalian heart cells. Biophys. J. 37: 342a (Abstr.). 37 McCans, J. L., G. E. Lindenmayer, R. G. Munson, R. W. Evans & A. Schwartz. 1974. A dissociation of positive staircase (Bowditch) from ouabain-induced positive inotropism: use of verapamil. Circ. Res. 35: 439–447. 38 Nayler, W. G. & J. Szeto. 1972. Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscle. Cardiovasc. Res. 6: 120–128. 39 Bayer, R., R. Hennekes, R. Kaufmann & R. Mannhold. 1975. Inotropic and electrophysiological actions of verapamil and D600, in mammalian myocardium. I. Pattern of inotropic effects of the racemic compounds. Naunyn-Schmiedeberg's Arch. Pharmakol. 290: 49–68. 40 Wit, A. L. & P. F. Cranefield. 1974. Effect of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant atrioventricular nodal tachycardia. Circ. Res. 35: 413–425. 41 Tritthart, H., R. Volkmann, R. Weiss & H. Eibach. 1976. The interrelationship of calcium-mediated action potentials and tension development in rat ventricular myocardium. J. Mol. Cell. Cardiol. 8: 249–261. 42 Nabata, H. 1977. Effects of calcium-antagonistic coronary vasodilators on myocardial contractility and membrane potentials. Jpn. J. Pharmacol. 27: 239–249. 43 McDonald, T. F., D. Pelzer & W. Trautwein. 1980. On the mechanism of slow calcium channel block in heart. Pflügers Arch. 385: 175–179. 44 Pelzer, D., W. Trautwein & T. F. McDonald. 1982. Calcium channel block and recovery from block in mammalian ventricular muscle treated with organic inhibitors. Pflügers Arch. 394: 97–105. 45 Tung, L. & M. Morad. 1983. Voltage- and frequency-dependent block of diltiazem on the slow inward current and generation of tension in frog ventricular muscle. Pflügers Arch. 398: 189–198. 46 Kass, R. S. 1982. Nisoldipine: a new, more selective calcium current blocker in cardiac Purkinje fibers. J. Pharmacol. Exp. Ther. 223: 446–456. 47 Krähenmann, R. & P. Heistracher. 1980. Electrophysiological studies of the effects of 5,6-dimethoxy-2-[3-([α-(3,4-dimethoxy) phenylethyl] methylamine) propyl] phtalmidine (AQA39) in isolated cardiac muscle. Naunyn-Schmiedeberg's Arch. Pharmakol. 311 (Suppl.): R36. 48 Lillie, C. & W. Kobinger. 1980. AQ-A39, 5,6-dimethoxy-2-[3-([α-(3,4-dimethoxy) phenylethyl]methylamino) propyl] phtalmidine, a substance which reduces heart rate specifically at the sinus node. Naunyn-Schmiedeberg's Arch. Pharmakol. 311: (Suppl.) R35. 49 Osterrieder, W., D. Pelzer, Q. F. Yang & W. Trautwein. 1981. The electrophysiological basis of the bradycardic action of AQA39 on the sinoatrial node. Naunyn-Schmiedeberg's Arch. Pharmakol. 317: 233–237. 50 Bayer, R., D. Kalusche, R. Kaufmann & R. Mannhold. 1975. Inotropic and electrophysiological actions of verapamil and D600 in mammalian myocardium. III. Effects of the optical isomers on transmembrane action potentials. Naunyn-Schmiedeberg's Arch. Pharmakol. 290: 81–97. 51 Nawrath, H., I. Blei, R. Gegner, C. Ludwig & X-G. Zong. 1981. No stereospecific effects of the optical isomers of verapamil and D-600 on the heart. In Calcium antagonism in cardiovascular therapy. A. Zanchetti & D. M. Krikler Eds.: 52–63. Excerpta Medica. Amsterdam . 52 Mason, J. W., L. M. Hondeghem & B. G. Katzung. 1983. Amiodarone blocks inactivated Na+ channels. Circulation 66: II–292 (Abstr.). 53 Mubagwa, K. & E. Carmelet. 1981. Electrophysiological effects of acetyl choline on rabbit cardiac Purkinje fibers. Arch. Int. Pharmacodyn. Ther. 249: 326–327. 54 Noma, A. & W. Trautwein. 1978. Relaxation of the Ach-induced potassium current in the rabbit sinoatrial node cell. Pflügers Arch. 377: 193–200. Citing Literature Volume427, Issue1Clinical Aspects of Life‐Threatening ArrhythmiasNovember 1984Pages 1-15 ReferencesRelatedInformation" @default.
• W1963526020 created "2016-06-24" @default.
• W1963526020 creator A5051925167 @default.
• W1963526020 date "1984-11-01" @default.
• W1963526020 modified "2023-09-27" @default.
• W1963526020 title "SELECTIVITY OF ANTIARRHYTHMIC DRUGS AND IONIC CHANNELS: A HISTORICAL OVERVIEW" @default.
• W1963526020 cites W1981478211 @default.
• W1963526020 cites W1995437073 @default.
• W1963526020 cites W1997429404 @default.
• W1963526020 cites W1998782346 @default.
• W1963526020 cites W2005112285 @default.
• W1963526020 cites W2005912313 @default.
• W1963526020 cites W2019273349 @default.
• W1963526020 cites W2025425361 @default.
• W1963526020 cites W2031291544 @default.
• W1963526020 cites W2031736892 @default.
• W1963526020 cites W2034150239 @default.
• W1963526020 cites W2041082563 @default.
• W1963526020 cites W2044258145 @default.
• W1963526020 cites W2045257946 @default.
• W1963526020 cites W2048978059 @default.
• W1963526020 cites W2055166534 @default.
• W1963526020 cites W2056547258 @default.
• W1963526020 cites W2063123325 @default.
• W1963526020 cites W2069884282 @default.
• W1963526020 cites W2090350951 @default.
• W1963526020 cites W2105331834 @default.
• W1963526020 cites W2113759120 @default.
• W1963526020 cites W2115052737 @default.
• W1963526020 cites W2115398125 @default.
• W1963526020 cites W2116411564 @default.
• W1963526020 cites W2116544026 @default.
• W1963526020 cites W2124237799 @default.
• W1963526020 cites W2124743911 @default.
• W1963526020 cites W2125550345 @default.
• W1963526020 cites W2145671207 @default.
• W1963526020 cites W2147101763 @default.
• W1963526020 cites W2150142099 @default.
• W1963526020 cites W2161601876 @default.
• W1963526020 cites W2166382926 @default.
• W1963526020 cites W2167852072 @default.
• W1963526020 cites W2176510798 @default.
• W1963526020 cites W2413621552 @default.
• W1963526020 cites W2995844318 @default.
• W1963526020 doi "https://doi.org/10.1111/j.1749-6632.1984.tb20771.x" @default.
• W1963526020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6331247" @default.
• W1963526020 hasPublicationYear "1984" @default.
• W1963526020 type Work @default.
• W1963526020 sameAs 1963526020 @default.
• W1963526020 citedByCount "17" @default.
• W1963526020 countsByYear W19635260202013 @default.
• W1963526020 crossrefType "journal-article" @default.
• W1963526020 hasAuthorship W1963526020A5051925167 @default.
• W1963526020 hasConcept C145148216 @default.
• W1963526020 hasConcept C178790620 @default.
• W1963526020 hasConcept C185592680 @default.
• W1963526020 hasConcept C2182769 @default.
• W1963526020 hasConcept C71924100 @default.
• W1963526020 hasConcept C98274493 @default.
• W1963526020 hasConceptScore W1963526020C145148216 @default.
• W1963526020 hasConceptScore W1963526020C178790620 @default.
• W1963526020 hasConceptScore W1963526020C185592680 @default.
• W1963526020 hasConceptScore W1963526020C2182769 @default.
• W1963526020 hasConceptScore W1963526020C71924100 @default.
• W1963526020 hasConceptScore W1963526020C98274493 @default.
• W1963526020 hasIssue "1 Clinical Aspe" @default.
• W1963526020 hasLocation W19635260201 @default.
• W1963526020 hasLocation W19635260202 @default.
• W1963526020 hasOpenAccess W1963526020 @default.
• W1963526020 hasPrimaryLocation W19635260201 @default.
• W1963526020 hasRelatedWork W1531601525 @default.
• W1963526020 hasRelatedWork W2319480705 @default.
• W1963526020 hasRelatedWork W2384464875 @default.
• W1963526020 hasRelatedWork W2606230654 @default.
• W1963526020 hasRelatedWork W2607424097 @default.
• W1963526020 hasRelatedWork W2748952813 @default.
• W1963526020 hasRelatedWork W2899084033 @default.
• W1963526020 hasRelatedWork W2948807893 @default.
• W1963526020 hasRelatedWork W3031052312 @default.
• W1963526020 hasRelatedWork W2778153218 @default.
• W1963526020 hasVolume "427" @default.
• W1963526020 isParatext "false" @default.
• W1963526020 isRetracted "false" @default.
• W1963526020 magId "1963526020" @default.
• W1963526020 workType "article" @default.